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ABSTRACT 
Clinicians are using transcranial magnetic stimulation (TMS) as a 
noninvasive tool to treat depression; however, standards for determining the 
motor threshold (MT), which often determines the final location of the TMS coil 
and the intensity of simulation for the depression treatment, are not clear. This 
study compared the observation of movement (OM) method and 
electromyography (EMG) method of determining motor threshold in a group of 
experienced TMS administrators and nurses with no previous MT knowledge. 
We hypothesized that between methods and groups the MT estimates would 
vary by < 50/0 of stimulator output and the ideal motor scalp location between 
methods would vary by < 1 cm. 
TMS administrators determined the MT twice with each MT method on 
one subject in a randomly assigned order. The subject and administrators were 
blind to TMS machine output. After determining the ideal motor scalp location, 
each TMS administrator then used the 5 cm rule to locate the optimal prefrontal 
treatment site. The scalp position over the anatomical hand knob and the EEG 
F3 position were located for comparison. 
There was no significant difference in the motor threshold estimates 
between the OM and EMG MT methods (t(14)=0.659, p=0.521). The mean EMG 
and OM MT estimates were (61.80/0 (sd=7.25) and 63.1 % (sd=9.05). Therewas 
no effect for the interaction between estimation method and experience level 
(F(1,13)=0.036, p=0.851) on MT estimates. The mean distance between the MT 
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sites and the hand knob was 21.25 (sd=8.98), while the mean distance between 
the treatment sites and F3 was 36.16 (sd=12.15). 
The wide range of MT estimates and motor scalp locations reveals several 
problems with the MT procedure for the OM and EMG methods. The standard 
EMG or OM methods along with the 5 cm rule may position the coil posterior and 
medial to the intended treatment location. 
This study shows that nurses with minimal MT training can determine the 
MT and localize the treatment site as effectively as experienced TMS operators. 
Information obtained from this study can be used to establish MT protocols and 




Transcranial magnetic stimulation (TMS) is a new noninvasive technology 
experiencing exponential growth as a treatment for depression and nurses have 
an opportunity to shape its treatment and training protocols. TMS involves strong 
oscillating magnetic pulses applied to the scalp with a metal coil that are strong 
enough to cause neuronal depolarization. In October of 2008, the United States 
Food and Drug Administration (FDA) cleared a TMS device as a treatment for 
unipolar depression (Tillman, 2008). TMS is for prescription use and must be 
administered by a medically trained person. The nurses' medical knowledge and 
ability to manage potential side effects caused by TMS makes them well suited to 
deliver TMS treatments. Prescribing clinicians and nurses need standards for 
determining dose and treatment location to ensure treatment uniformity across 
TMS clinics. 
In the way clinicians currently apply TMS, motor threshold determination is 
a fundamental element of a successful TMS treatment for depression. MT is an 
estimate of cortical excitability that varies within individuals, and which 
determines the final location of the coil and the intensity of simulation for the 
depression treatment (Rossini et aI., 1999). Traditionally, researchers have 
determined MT by applying TMS over the motor cortex and recording motor 
evoked potentials (MEP) of the relaxed target muscle with an electromyography 
(EMG) device (Barker, Jalinous, & Freeston, 1985). After finding MT, the 
depression researcher moves the TMS coil 5 em forward in order to stimulate the 
prefrontal cortex (George et aI., 1995). More recently, the observation of 
movement (OM) method of MT determination has gained popularity with 
clinicians treating depression with TMS. The widespread adoption of the OM 
method over the EMG assisted method for MT determination has occurred with 
only four small studies directly comparing the two methods (8alslev, Braet, 
McAllister, & Miall, 2007; Conforto, Z'Graggen, Kohl, Rosier, & Kaelin-Lang, 
2004; Hanajima et aI., 2007; Pridmore, Fernandes Filho, Nahas, Liberatos, & 
George, 1998). 
Standardizing the MT procedure is important to compare treatment 
outcomes across TMS studies and to deliver TMS at the proper location within 
the published safety guidelines (Wassermann, 1998). This translational research 
study compared the intensity and location of OM MTs to EMG MTs. We tested 
results from studies conducted previously which suggest that the range of MT 
estimates between EMG and OM methods will be within 5% of total machine 
output, and that the MT scalp locations would not vary widely, being within a 1 
em area. We examined the location and distance achieved with the 5 em rule 
applied after the OM MT and EMG MT. Investigators then compared the MT and 
treatment locations found by the newly trained nurses to those found by 
experienced TMS administrators. Also compared were MT scalp locations to 
hand knob, and treatment locations to F3. 
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This document consists of three manuscripts. The first manuscript is a 
literature review of methods and techniques of MT determination. The second 
manuscript compares the OM and EMG MT methods in a group of experienced 
TMS administrators and nurses with no previous TMS experience. The third 
manuscript is an introduction to TMS in clinical settings for nurses with limited 
TMS knowledge. This document will provide nurses with a better understanding 
of TMS and the MT methods. Additional training will be required before a 
clinician should administer TMS. 
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MANUSCRIPT 1- REVIEW OF THE LITERATURE 
This manuscript has been published in the Journal of the American Psychiatric 
Nurses Association: Anderson, B. S. and George, M.S. (2009). A Review of 
Studies Comparing Methods for Determining Transcranial Magnetic Stimulation 
(TMS) Motor Threshold - Observation of Movement or EMG-Assisted. 
INTRODUCTION: 
Repetitive transcranial magnetic stimulation (rTMS) is a noninvasive 
technique cleared by the United States Food and Drug Administration (FDA) in 
October of 2008 for patients with unipolar depression who have failed to respond 
to at least one antidepressant medication in their current depressive episode. 
Clinicians apply rTMS by placing an insulated metal coil on the patient's scalp 
and passing brief oscillating electric current through the coil, thus generating 
magnetic fields that pass unimpeded through the hair, skin, and bone to cause 
neural depolarization. Patients remain awake and alert during the rTMS 
procedure. The most common rTMS side effects are discomfort at the site of 
stimulation and headache. Unlike electroconvulsive therapy, rTMS does not 
require a seizure for therapeutic benefit. However, rTMS has caused 
unintentional seizures on rare occasions (Conca, Konig, & Hausmann, 2000; 
Nowak, Hoffmann, Connemann, & Schonfeldt-Lecuona, 2006; Tharayil, 
Gangadhar, Thirthalli, & Anand, 2005; Wassermann, 1998). 
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The motor threshold (MT) is an estimate of cortical excitability that 
quantifies the dose of rTMS; its location provides a reference for the treatment 
site. MT estimates vary between individuals but are relatively stable within 
subjects over time (Rossini et aI., 1999). Psychiatric nurses and other clinicians 
using rTMS as a treatment for depression estimate the MT with the observation 
of movement (OM) method or the electromyography (EMG) assisted method to 
establish treatment dose. 
Traditionally, neurophysiologists have estimated MT by applying the TMS 
coil over the motor cortex in a grid like pattern and recording motor evoked 
potentials (MEP) of the relaxed or resting target muscle of the abductor pollicis 
brevis (APB) or the first dorsal interosseus (FOI) with an EMG (Barker et aI., 
1985). The resting motor threshold (rMT) target muscles are not active and are 
not opposing gravity while active motor threshold (aMT) muscles are typically 
engaged to a specific measurement of force, measured with a strain gauge. For 
the purposes of this manuscript, all MT refers to resting MT unless otherwise 
noted. More recently, some researchers, particularly those administering rTMS 
in clinical research trials, have used an alternative method of determining MT that 
does not utilize an EMG machine called the observation of movement or 
visualization method. Instead of positive MEPs, the OM method substitutes 
observed movements of the thumb, wrist, or fingers. In different variants of the 
OM method, clinicians may limit positive movements to the target muscle or may 
accept movements from the whole hand. 
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It is unclear whether the OM method produces MTs similar to the EMG-
assisted method. Perhaps the first to introduce the idea of watching for a visible 
contraction of the APB muscle when determining the motor threshold were 
investigators of a study working with obsessive-compulsive patients who had 
concerns about germs and hand skin contact (Greenberg, Ziemann, Harmon, 
Murphy, & Wassermann, 1998). Their study did not attempt to compare the 
EMG-assisted and OM methods, nor did it suggest that the OM method should 
replace the EMG-assisted method. Nevertheless, many researchers began 
using the less expensive and expedient OM method. 
Clinicians express the power required for reliable motor responses as a 
percent of total machine output and dose treatment relative to this number. This 
manner of expressing the dose of rTMS does not quantify the magnetic field 
strength of the TMS coil. Although it references the dose to the excitability level 
of the patient, it is not a measurable quantifiable unit such as the induced 
magnetic field. Consequently, the same magnetic intensity may not be delivered 
·to different patients even if prescribed the same dose of MT (e.g. 100% ) because 
of their differing MTs. 
Several motor threshold estimating techniques are combined with EMG or 
OM to establish the MT estimate (Table 1) (Awiszus, 2003; Herwig et aI., 2002; 
Mills & Nithi, 1997; Mishory et aI., 2004; Pridmore et aI., 1998; Rossini et aI., 
1994; Rothwell et aI., 1999). Early MT guidelines by Rossini et al. suggested that 
TMS machine output should be slowly increased until MEP amplitudes of 100 IJV 
in 50% of 10 consecutive stimuli are recorded. Other researchers have 
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condensed this MT recommendation to allow for MEP amplitudes of 50 f.,JV and 
three positive responses out of six stimuli (Herwig et aI., 2002). A different 
method of determining MT, which calls for an upper and lower threshold, was 
presented by Mills and Nithi. They defined the upper threshold as 10 
consecutive positive responses with MEPs of 20 f.,JV. Conversely, the lower 
threshold is 10 negative responses. The average of the upper and lower 
thresholds yields the overall MT for an individual. 
The maximum-likelihood strategy (MLS) is a fourth approach of estimating 
the MT (Awiszus, 2003; Mishory et aI., 2004). The MLS method uses a 
computerized algorithm that dictates the next intensity of machine output based 
on negative and positive responses (50-100 f.,JV) to stimuli. The predictive power 
and efficiency of the maximum-likelihood strategy reduces the number of total 
pulses needed and may increase accuracy (Awiszus, 2003; Awiszus, Feistner, 
Urbach, & Bostock, 1999; Mishory et aI., 2004). The previously mentioned 
physiological techniques rely on the assistance of an EMG, though many 
clinicians simply apply these formulas to the OM method. 
Another concern for rTMS clinicians is finding the motor threshold "hot 
spot" or optimal location where the "threshold is the lowest and the onset latency 
is shortest" (Rossini et aI., 1994). In a recent study, researchers examined five 
localization techniques (center of gravity, International 10-20 
electroencephalography (EEG) system, fMRl, group fMRl, and MEP of maximal 
amplitude) and concluded that stereotactically guided coil placement has the 
greatest precision (Sparing, Buelte, Meister, Paus, & Fink, 2008). However, 
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precise MRI guided positioning is controversial, finding differences with a 
behavioral (e.g. movement) approach. That is, one can base the coil position 
guided by brain structural anatomy (the hand knob for thumb movement) as seer 
on MRI, or the functional region that is activated with thumb movement as 
determined by blood-oxygen-Ievel dependent functional MRI, or by simply 
behaviorally searching for the optimum scalp location where the TMS coil best 
produces thumb movement. These different approaches to placement, as 
indicated in the Denslow study, do not result in the same scalp position for the 
coil, even for something as simple as thumb movement (Denslow, Bohning, 
Bohning, Lomarev, & George, 2005; Denslow, Lomarev, Bohning, Mu, & George, 
2004; Denslow, Lomarev, George, & Bohning, 2005). Moreover, most research 
labs and clinics performing rTMS as a treatment for depression do not have 
expensive MRI and frameless stereotactic equipment available and simply 
substitute the less costly International 10-20 EEG system or MEP of maximal 
amplitude method to find the optimal MT location and final treatment position. 
Depression researchers are still using a variety of rTMS treatment 
techniques with mixed outcomes. Recent randomized controlled trials of rTMS 
as a treatment for depression are compared in Table 2. These studies have at 
least 15 subjects in each group and were published from January 2007 to July 
2008 (Fitzgerald et aI., 2008; Herwig et aI., 2007; Jorge, Moser, Acion, & 
Robinson, 2008; Loo, Mitchell, McFarquhar, Malhi, & Sachdev, 2007; Mogg et 
aI., 2007; Q'Reardon et aI., 2007b). All the depression studies reviewed in table 
2 target the prefrontal cortex (PFC) as the optimal treatment location. Most of 
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these studies used the MT dependent 5 cm rule to locate the prefrontal cortex 
position. Other studies relied on the International 10-20 EEG system, which is 
not influenced by the location of the MT. All studies used the MT value to 
calculate the TMS dose, yet the stimulation parameters were not uniform across 
studies. It is apparent that researchers using rTMS as a treatment for depression 
rely on MT to determine the dose of TMS and sometimes use the position 
established for the MT to determine the treatment location. 
Standardizing the motor threshold procedure is important to compare 
treatment outcomes across rTMS studies and to deliver rTMS within the 
published safety guidelines (Wassermann, 1998). This paper critically reviews 
the evidence comparing the OM method to the EMG-assisted method for 
determining motor threshold. 
METHODS: 
To uncover literature that compares the OM method to the EMG-assisted 
method for determining MT, the authors collected published articles written in 
English from January 1995 through April 2008 by systematically searching the 
electronic database Medline. Authors combined the keyword terms: transcranial 
magnetic stimulation, motor threshold, motor evoked potentials and movement to 
narrow the focus of the search. Fifty-five citations were found. Authors then 
reviewed the abstracts of all articles for relevance to this paper's objective. In 
addition to electronic searches, the authors searched references in TMS articles 
and consulted TMS experts by posting to the list server of the International 
Society for Transcranial Stimulation. Appropriate articles are summarized in 
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Table 3 using an evidence grading system (Greer, Mosser, Logan, & Halaas, 
2000). 
RESULTS: 
Though fifty-five articles were identified, only four articles provided a direct 
comparison of the two methods under review (Table 3) (Balslev et aI., 2007; 
Conforto et aI., 2004; Hanajima et aI., 2007; Pridmore et aI., 1998). The first and 
most cited study comparing the two methods of determining MT was by Pridmore 
and colleagues in 1998. This study involved six right-handed male researchers 
between the ages of 29-50 years. Researchers used a Dantec MagPro (Dantec 
Medical, Medtronic Inc, Minneapolis, MN) with a figure-8 coil to deliver 
stimulation. This TMS machine, unlike more modern systems, has a relatively 
crude dial for changing the intensity and delivers TMS in 5% output gradations. 
Pridmore et al. (1998) started with supramaximal stimulation over the site 
of greatest sensitivity then decreased machine output by approximately 2%. The 
technique used to find the optimal motor location was not presented. The EMG-
assisted MT used the lowest intenSity setting which produced MEP amplitude of 
at least 50 IJV in at least five out of ten stimulations in the APB muscle; while the 
OM method substituted any movement of the whole hand for MEPs. Each 
subject had two sessions in a random order. They concluded that the OM 
method of determining MT was roughly similar to the EMG-assisted method 
when using a TMS machine with limited dial output gradations and allowing any 
movement in the hand or wrist to count as a positive response. That is, the 
difference between the two MT determining techniques was less than the 50/0 
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fixed difference in output built into the machine making the two techniques yield 
'near-equivalent' results on that machine. 
This study by Pridmore et al. (1998) laid the groundwork for the use of the 
OM method in some clinical TMS treatment settings. In spite of the paucity of 
research, many research labs and clinicians began using the OM method based 
solely on this limited information even when they were using machines with 10/0 
output gradations. Pridmore et al.'s sample of six men is small and 
underpowered, capable of only finding very large effects, especially considering 
the variable nature of the motor threshold (Wasserman, 2002). Because TMS 
delivered over the motor cortex at low frequencies of 1 Hz can alter the MT, 
Rothwell et al. (1999) suggested separating pulses by more than three seconds 
when determining the MT. Pridmore et al. did not explicitly state the interval 
between TMS pulses, but rather provided the non-specific rate of <1 Hz. It is 
important to realize that the EMG-assisted method Pridmore et al. used relied on 
MEPs only from the APB muscle, but then counted any movement of the 
contralateral hand during the OM method. Pridmore et al. found that five out of 
six subjects had a lower MT value with whole hand OM than with EMG-assisted. 
However, no subject showed a difference of more than 40/0 of machine output. 
Despite the limitations of this study, Pridmore et al. set the stage for the use of 
the OM method for determining motor threshold in clinical settings, thus 
potentially reducing the time and expense of the procedure and allowing for 
treatment in settings other than neurophysiology laboratories. 
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The second published study that directly compared the EMG-assisted and 
OM methods for determining motor threshold was by Conforto et at (2004). 
They proposed the term movement threshold be assigned to the OM method and 
motor threshold refer to "thresholds measured with MEP evaluation". Conforto et 
al. expanded on previous work and stimulated in a block-randomized fashion 
over APB and a fixed scalp position in 16 healthy subjects. The nasion-inion line 
and interauralline cross at the vertex of the head and the fixed position site was 
marked on a swim cap 5 cm left of the vertex on the interaural line. Stimulation 
for locating the optimal APB site started at 70% machine output and decreased 
by 5% increments while meticulously searching in half-centimeter increments 
until no MEPs greater than 1 OO~V were recorded at APB, FDI, and bicep brachii 
(BB). Then the motor threshold was determined by increasing the machine 
output until 5 out of 10 trials produced MEPs of at least 50~V. The movement 
threshold used the same five out of ten rule but counted any movement of the 
fingers or wrist just as Pridmore et al. (1998) described. 
Conforto et al. (2004) more than doubled the sample size of the previous 
study and provided an explicit explanation of how to find the optimal site to 
stimulate over APB. However, the method used by Conforto et al. to determine 
movement threshold relied on EMG to find the optimal location and ensure the 
muscle was at rest before stimulation occurred. The standard OM method as 
described by Pridmore and colleagues in 1998 includes movements of the whole 
hand and does not have a system that monitors voluntary muscle contractions or 
motor tensing that might alter the motor threshold. Conforto et al. used an MEP 
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monitoring system that identified one subject with voluntary muscle contractions. 
They removed this subject's data from the final analysis due to his contracted 
muscles during stimulation. Conforto et al. did not examine the critical 
components of finding the optimal spot to stimulate the APB using the OM 
method. This limits the usefulness of their findings in TMS clinical settings that 
lack EMG equipment. 
Conforto et al. (2004) found that, overall, resting motor thresholds (EMG-
assisted method) were lower than movement thresholds (whole hand OM 
method), while Pridmore et al. (1998) concluded the opposite in 5 out of the 6 
subjects studied. Conforto et al. did not provide the raw thresholds for each 
subject; rather, they gave the group means for movement and motor thresholds, 
which were within 2% of machine output. While this mean difference is small, it 
appears that one subject had a 12% machine output difference between the two 
methods. The outlier with the largest difference in the percent of machine output 
may be unique or represent a problem with the OM method. As the group mean 
difference between the EMG-assisted and OM methods was only 2%, the overall 
conclusion by Pridmore et al. was upheld. 
In 2007 both Hanajima et al. and Balslev et al. reported that the EMG-
assisted method overall produced lower resting motor thresholds than did the 
OM method, confirming findings by Conforto et al. (2004). However, there were 
differences in the methods of these studies. The two earlier studies targeted the 
relaxed APB muscle for the EMG method and accepted any movement of the 
whole hand for the OM method. Alternatively, both Hanajima et al. and Balslev 
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et al. limited positive responses to twitches or appropriate MEP amplitudes of the 
relaxed FDI muscle. Movements of muscles other than the FDI muscle did not 
constitute a positive response. In a small sample of 10 subjects, Hanajima et al. 
compared five different methods of determining motor threshold in both relaxed 
and active muscles. Balslev et al. compared resting MTs of four subjects from a 
larger study examining the effect coil position has on MT. The mean MT 
difference between the EMG-assisted and OM method was 6% and 2% machine 
output respectively for Hanajima et al. and Balslev et al. Like their predecessors, 
Hanajima et al. and Balslev et al. found the optimal motor location for each 
subject and gave all stimulation over this area. All four of the reviewed MT 
studies used magnetic stimulators with figure eight flat coils. 
DISCUSSION: 
Despite the relatively small evidence to support the assertion that the OM 
method is similar to the EMG-assisted method for determining motor threshold in 
clinical settings, many clinicians are using the faster, less complicated OM 
method. The pivotal FDA trial for rTMS in depression used the OM method and 
clinical settings treating depression with rTMS have adopted it (O'Reardon et aI., 
2007). However, it is important to remember that the rTMS safety tables were 
published using EMG determined MTs and do not account for possible 
differences with other methods (Wassermann, 1998). 
The four studies that have directly compared the various motor threshold 
methods have yielded somewhat opposing findings. The total number of 
subjects in all four of these studies is 35. In addition, none of these studies 
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addressed how to use the OM method to find the optimal site to stimulate the 
target muscle. In depression studies, the APB is often the target and the rTMS 
treatment is delivered 5 cm anterior of this spot (George et aI., 1995). The 
incorrect identification of the APB location may preclude the rTMS treatment from 
occurring over the prefrontal cortex as designed. Pridmore et al. (1998) 
considered any movements of the hand or wrist as acceptable positive 
responses to stimuli, and Conforto et al. (2004) repeated this liberal strategy. 
The EMG-assisted method focuses on recording MEPs from a more defined area 
than the entire hand or wrist and thus provides a more accurate location of the 
optimal spot to stimulate. If the APB is the target, then clinicians should consider 
only thumb movement as a positive response when determining optimal MT 
location. 
The EMG-assisted method ensures delivery of stimulation to a relaxed 
muscle, which is critical as contracted muscles can produce larger MEPs than 
relaxed muscles that receive the same intensity of stimulation (Oi Lazzaro et aI., 
1998; Hanajima et aI., 2007). Contracted muscles may yield erroneous positive 
responses, which may be problematic for new computerized algorithms that rely 
on fewer stimuli to achieve the final MT, rendering them more influenced by false 
positive or negative responses. 
Function-based techniques like the EMG-assisted and OM methods, 
where the scalp location is referenced to the motor APB location, do not reliably 
position the coil over the target area (Herwig, Pad berg, Unger, Spitzer, & 
Schonfeldt-Lecuona,2001). The International 10-20 EEG system or image 
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guided positioning are other techniques to consider when positioning the TMS 
coil. Perhaps this would reduce TMS administrator error introduced when 
placing the coil for treatment. 
Calculating the TMS dose based on MT has long been a practice to 
ensure the safety of the patient (Wassermann, 1998). Functional responses over 
the motor cortex may not correlate to a safe and effective treatment over different 
areas of the brain. More research is needed to determine the optimal and safe 
dose of TMS pver each target area. At present, there is a lack of consensus on 
how best to perform the motor threshold procedure. Clearer guidelines for 
determining MT, which are paramount to a safe and likely effective treatment, 
would help the field. As the safety data concerning TMS were established with 
the EMG and the available evidence supporting the OM method is sparse; 
additional studies are needed to directly compare the two approaches. For 
research and clinical application where the stimulation parameters are at or near 
the safety guidelines, or involve scalp locations or patient populations at risk of 
seizure, the EMG-assisted method is a more conservative approach. 
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Table 1. Techniques for estimating the motor threshold. 
Citation Response EMG Interstimulus Starting 
Criteria amplitude or Interval Stimulation 
OM method Intensity 
Rossini et 500/0 of 10- EMG-100 ~V n/a Subthreshold 
aL, 2004 20 
consecutive 
stimuli 
Rothwell et 500/0 of 10- EMG-50 ~V 3 seconds Suprathreshold 
aL, 1999 20 
consecutive 
stimuli 
Mills & 10 EMG-20 ~V 3 seconds Subthreshold 






Pridmore et 5 out of 10 EMG-50 ~V <1 Hz Suprath reshold 




Herwig et 3 out of 6 EMG-50 ~V 2 seconds n/a 
aI., 2002 
Awiszus, Algorithm EMG-50 ~V 3.5 seconds Subthreshold 
2003 
Mishory et 3 out of 6 OM method- 3 seconds Suprathreshold 
aL,2004 any finger 
movement. 
Algorithm 3 seconds Suprathreshold 
EMG-100 ~V 
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Table 2. Randomized controlled trials of rTMS as a treatment for depression (January 2007 - July 2008). 
Citation Design/ Subjects Parameters Coil Placement technique Outcome/Results 
Herwig et Blinded, randomized Sham or active stimulation. Device: Magstim Rapid with Response was defined as a 
aI., 2007 controlled trial of 127 figure-eight coil. decrease in total score of 500/0 
subjects with unipolar Tx location: left OLPFC on at least two scales (HRSD-
or bipolar disorder. Frequency: 10Hz rMT method: EMG-assisted 21, MAORS, or BOI). 
On time: 2 sec method. 
In addition to active or Off time: 8 sec At 3 weeks: 
sham rTMS, all Intensity: 110% rMT Tx location: Over F3 using the Active group (n=52) response 
subjects received # of pulses/day: 2,000 International 10-20 system. rate 31 %1. 
venlafaxine or # of pulses/study: 30,000 Sham group (n=53) response 
mirtazapine. rate 31 %. 
Sham stimulation was given 
above the left temporal 
muscle with an active coil 
angled at 45 degrees. 
Loo et aI., Blinded, randomized Sham or active stimulation. Device: Magstim Super Rapid Response was defined as a 
2007 controlled trial of 36 with a 70 mm figure-eight coil. decrease in the MAORS total 
subjects with unipolar Tx location: left PFC score of at least 50% from 
depression. Frequency: 10Hz rMT method: EMG-assisted baseline. 
On time: 5 sec method with the APB as the 
Subjects (n=36) were Off time: 25 sec target. Active group response rate 
medication free or Intensity: 110% rMT 33.30/0. 
stable on an # of pulses/day: 3,000 Tx location: The 5 cm rule was Sham group response rate 
antidepressant. # of pulses/study: 30,000 applied to reach the left PFC. 16.6%. 
Two rTMS sessions a day for 
2 weeks. 




Citation Design/ Subjects Parameters Coil Placement technique Outcome/Results 
Mogg et Blinded, randomized Sham or active stimulation. Device: Magstim Super Rapid Response was defined as a 
al.,2007 controlled trial of 59 with figure-eight coil. decrease in the HRSD-17 total 
subjects with unipolar Tx location: left PFC score of at least 50% from 
depression. Frequency: 10Hz rMT method: OM method with the baseline. 
On time: 5 sec APB muscle as the target and 
Antidepressants Off time: 55 sec lowest intensity in 3 out of 6 trials. Remission defined as 17 -item 
remained stable. Intensity: 110% rMT HRSD < 9. 
# of pulses/day: 1,000 Tx location: The 5 cm rule was 
# of pulses/study: 10,000 applied to reach the right PFC. Active group (n=28) response 
rate 32%. 
Sham stimulation given with a Sham group (n=29) response 
sham coil that looks identical rate 10%. 
to the real coil, but does not 
introduce a magnetic field to Active group (n=28) remission 
the brain. rate 25%. 




O'Reardon Blinded, randomized Sham or active stimulation. Device: Neuronetics Model 2100 Response was defined as a 
etal., 2007 controlled trial for Therapy System. decrease in the MADRS total 
unipolar depression. Tx location: left DLPFC score of at least 50% from 
Frequency: 10Hz rMT Method: OM method with the baseline. 
Active group n=155 On time: 4 sec assistance of a mathematical 
Sham group n=146 Off time: 26 sec algorithm. After 4 weeks of rTMS: 
Intensity: 120% rMT Active group response rate 
# of pulses/day: 3,000 Tx location: The 5 cm rule was 18.10/0. 
# of pulses/study: 60,000- applied to reach the left PFC. Sham group response rate 
90,000 11.0%. 
Sham stimulation given with a After 6 weeks of rTMS: 
sham coil that looks identical Active group response rate 
to the real coil, but does not 23.9%. 
introduce a magnetic field to Sham group response rate 
the brain. 12.3%. 
'---
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Citation Design/ Subjects Parameters Coil Placement technique Outcome/Results 
Fitzgerald 60 subjects stable on All subject received active Device: Medtronic Magpro 30 with Response was defined as a 
etal.,2008 medication with stimulation over the right 70-mm, figure-eight coil. decrease in the MADRS total 
unipolar or bipolar PFC. score of at least 500/0 from 
disorder received Frequency: 1 Hz rMT method: OM method with the baseline. 
unblinded 1 Hz On time: 15 min APB muscle as the target and 
stimulation. Intensity: 110% rMT lowest intensity in 5 out of 10 
# of pulses/day: 900 trials. Active-priming + slow TMS 
In addition to this # of pulses/study: 9,000- response rate= 33%) 
treatment, Group A 18,000 Tx location: The 5 cm rule was 
received pretreatment applied to reach the right PFC. Sham-priming + slow TMS 
with 6 Hz stimulation Group A: Pretreatment response rate= 14 % 
and Group B received Tx location: right PFC 
sham in a blinded Frequency: 6 Hz 
fashion. On time: 5 sec 
Off time: 25 sec 
Intensity: 90% rMT 
# of pu Ises/day: 600 
# of pulses/study: 6,000-
12,000 
Group B: Pretreatment 
Sham stimulation was give 
with an active coil angled at 
45 degrees. 
Jorge et Blinded, randomized Experiment #1 Device: Magstim Super Rapid Response was defined as a 
aI., 2008 controlled trial for Sham or active stimulation. Stimulator; 70-mm, figure 8- decrease in the HRSD-17 total 
vascular depression. shaped butterfly coils. score of at least 50% from 
Tx location: left DLPFC baseline. 
92 antidepressant free Frequency: 10Hz rMT Methods: EMG-assisted 
subjects in experiment On time: 6 sec method with the FDI muscle as 
#1 were given sham Off time: 60 sec the target. MLS-PEST and 
TMS or 12,000 pulses Intensity: 1100/0 MT positive MEP in 5 out of 10 trials. Experiment #1. 
and in experiment #2 # of pulses/day: 1,200 Active group: response rate 
were given sham or __ # gfpulses/study: 12,000 Tx location: MRI guided over 33.3% 
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Citation Design/ Subjects Parameters Coil Placement technique Outcome/Results 
18,000 pulses. Brodmann area 46. Sham group: response rate 
Experiment #2 6.7%. 
Sham or active stimulation. 
Experiment #2. 
Tx location: left DLPFC Active group: response rate 
Frequency: 10Hz 39.4% 
On time: 6 sec Sham group: response rate 
Off time: 60 sec 6.9% 
Intensity: 110% rMT 
# of pulses/day: 1,200-2,400 
I 
# of pulses/study: 18,000 
--
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Table 3. Evidence comparing the EMG-assisted and OM methods for determining motor threshold (January 1995 
- April 2008). 
Citation Design type Population Primary Outcome Authors' Conclusions Limitations 
Studied/Sa Measures/Results 
mple Size 
Pridmore The OM method was 6 right- IThe mean difference IThe OM method and the EMG- The optimum spot for 
~t aI., compared to the EMG- handed between EMG assisted assisted method are similar; stimulation was located with the 
1998 assisted method for men aged method and OM method however, 5 out of 6 subjects assistance of EMG for both 
determining MT in the 29-50 ~as 1.7% of total had motor thresholds that were methods. 
relaxed APB muscle. years. stimulator output. lower when using the OM 
method. Observed thumb, fingers or 
Random order. rwrist movement was considered 
~ positive responds for the OM 
'The subjects and TMS method. 
operator were unblinded 
~o the condition. Small sample size. 
Conforto iThe OM method was 8 right- IThe mean difference The difference between the OM iThe optimum spot for 
et aI., compared to the EMG handed between EMG-assisted method and the EMG-assisted stimulation was located with the 
2004 assisted method for men and 8 method and OM method method were small; however, assistance of EMG for both 
determining MT in the women :was 1.9% of total 13 out of 14 subjects had motor methods. 
relaxed APB muscle. aged 21- stimulator output. ~hresholds that were higher 
29 years. rwhen using the OM method. Observed fingers or wrist 
Block randomization. movement was considered a 
positive responds for the OM 
A blinded investigator was method. 
used to observe 







Citation Design type Population Primary Outcome Authors' Conclusions Limitations Class / 
Studied/Sa Measures/Results Quality 
mple Size 
Hanajima Unblinded comparison of 7 right- Mean threshold values Motor thresholds were higher Irhe optimum spot for C, -
let aI., 5 different methods of handed RMT mov- 55.8% rwhen using the OM method. stimulation was located with the 
~007 determining MT in relaxed men and 3 AMT mov- 43.3% assistance of EMG for both 
and active muscles (FDI). Iwomen, RMT mov1- 51.6% methods. 
~ged 30- AMT mov1- 36.50/0 
MT mov- visible finger 53 years. RMTraw- 49.8% Small sample size. 
movements (8 out 16 AMTraw- 35.1 % 
~rials) AMTraw1 - 33.4% 
MT mov1- visible finger RMTrec- 47.0% 
movements (1 out 16 AMTrec- 29.4% 
~rials) 
MTraw- EMG assisted The mean difference 
(MEPs greater than 50uv between EMG-assisted 
in half of the trials). method (55.8) and OM 
MTrawr EMG assisted method (49.8) was 6% 
(MEPs greater than of total stimulator 
100uv in half of the trials). output. 
MTrec- intensity 1.3 times 
larges than mean 
background activity. 
Balslevet Irhe primary study ~ subjects The OM method The OM method and the EMG- Irhe optimum spot for A -, 
aI., 2007 evaluates coil orientation produced MTs that were assisted method are highly stimulation was not located with 
on MT, in a blinded higher on average by correlated. each method. 
~ashion, using the OM 20/0 of total stimulator 
method. In a subgroup of output. Small sample size. 
~his population, the EMG-
assisted method was 
applied to the FDI muscle. 
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MANUSCRIPT II - METHODS AND RESULTS 
To be submitted to the journal Brain Stimulation; A Comparison of the 
Observation of Movement Method and Electromyography Method of Determining 
Motor Threshold in Transcranial 'Magnetic Stimulation. 
INTRODUCTION: 
Transcranial magnetic stimulation (TMS) is a noninvasive technique in 
which clinicians' pass electricity through a metal coil producing brief oscillating 
magnetic pulses capable of depolarizing neurons directly below the coil's face. 
Activation of motor neurons allows clinicians to functionally map brain areas and 
estimate cortical excitability. In addition, TMS has several neurological and 
psychiatric treatment indications with the most promising being depression. 
Based on a large clinical trial, the United States Food and Drug Administration 
(FDA) approved a TMS device in the fall of 2008 for the treatment of unipolar 
depression in patients who have not experienced a response to one 
antidepressant medication in their current depressive episode (O'Reardon et al., 
2007a). 
Currently, the most frequently used location for treating depression is over 
the border of Brodmann areas 9 and 46 within the dorsolateral prefrontal cortex 
(DLPFC). The most common method used to localize the DLPFC involves first 
identifying the motor threshold of the abductor pollicis brevis (APB) muscle and 
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then moving the TMS coil 5 em anterior in a parasagital plain to the optimal 
treatment site. The dose or intensity of TMS treatments are based on excitability 
of the APB muscle (George et aI., 1995; George et aI., 1996). The motor 
threshold is the anchor for nearly all TMS depression studies and clinical TMS for 
depression (Anderson & George, 2009). 
Mapping APB MT site is the first step of a TMS treatment. Mapping is 
based on the center of gravity (COG) of motor evoked potentials (MEP) 
(Wassermann, McShane, Hallett, & Cohen, 1992). This technique requires that 
the clinician record MEPs from several points on a grid over the motor cortex 
then calculate the mean MEP amplitude. Clinicians using TMS to treat 
depression shortened the COG process by simply moving the coil over the motor 
cortex until they identify a strong MEP. This location is marked and called the 
motor threshold (MT) optimal location. With the coil over the scalp in what is 
assumed to be the location to best measure the MT, the lowest intensity or power 
that reliably depolarizes neurons and causes muscle activation is found and 
expressed as a percent of total machine output (Rossini et aI., 1994). Since 
there is no simple functional measure of DLPFC excitability, clinicians extrapolate 
the estimate of motor excitability for the TMS treatment (Kozel et al., 2000; 
McConnell et aI., 2001; Nahas et aI., 2001). Clinicians most often give 
depression treatments over the DLPFC at 100-120% of the MT estimate. 
Early TMS researchers used an electromyography (EMG) to record MEP 
of the contralateral APB muscle. This traditional EMG method was the standard 
for depression trials until an alternative was introduced in a small 1997 OCD trial 
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(Greenberg et aI., 1997). This newer MT method did not use an EMG device; 
rather, it simply replaced recorded positive MEPs with observed movements 
(OM) of the hand or fingers. Many depression researchers and TMS 
manufacturers adopted the OM method as standard practice for TMS delivery. 
Several small studies have compared the intensity of the EMG and OM 
methods of determining MT. None have considered the importance of coil 
placement (Anderson & George, 2009). In these studies, clinicians identified the 
optimal MT site with the EMG method and then used the alternative method over 
the same so called motor hot spot. Researchers assumed that the MT location is 
the same for each MT method. In addition, imaging studies suggest that the 5 
cm rule applied to the MT falls short of the intended treatment location, thus 
optimizing only 32% of TMS treatments (Herbsman et aI., 2009; Herwig et aI., 
2001; Herwig, Satrapi, & Schonfeldt-Lecuona, 2003). In current clinical practice, 
most TMS clinicians assume that the OM method is similar to the EMG method, 
the latter thought to determine the MT accurately in both location and intensity. 
Basic knowledge of TMS and brain anatomy is required to reduce the risk 
of seizure and to deliver an effective treatment. TMS training is not standardized 
and instructors have few guidelines to follow when teaching the next generation 
of TMS administrators. A medically trained person in seizure management 
should deliver TMS treatment. Many clinics rely on nurses to fulfill this role 
(Belmaker et aI., 2003; Pridmore, Khan, Rosa, & George, 2003). Most nurses 
are new to TMS and will need standardized training to ensure all patients receive 
appropriate stimulation. Our study involved training nurses on how to determine 
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the MT scalp location and intensity using the OM and EMG methods. In addition, 
nurses learned how to locate the DLPFC using the 5 cm rule. 
In this study, we compared the intensity and location of OM MTs to EMG 
MTs. We tested results from studies conducted previously which suggest that 
the range of MT estimates between EMG and OM methods will be within 50/0 of 
total machine output and that the MT scalp locations would not vary widely, being 
within a 1 cm area (Conforto et aI., 2004; Pridmore et aI., 1998; Sparing et aI., 
2008). We examined the location and distance achieved with the 5 cm rule 
applied after the OM MT and EMG MT. Investigators then compared the MTs 
and treatment locations found by the nurses to those found by experienced TMS 
administrators. Also compared were MT scalp locations to hand knob, and 
treatment locations to F3. 
METHODS AND MATERIALS: 
Fifteen TMS administrators and one healthy 35-year-old participated in the 
study. The subject and all TMS administrators signed the MUSC Institutional 
Review Board approved informed consent. Each TMS administrator preformed 
the MT procedure four consecutive times on the subject. There were two study 
groups, one comprised of ten experienced TMS administrators, the other 
comprised of five nurses with no previous MT knowledge. The nurses received a 
one to two hour didactic session on MT determination followed by one hour of 
practice on the subject. The nurses' MT sessions were not on the same day as 
their practice session. The non-nurses had at least one year of experience with 
TMS and did not receive extra training for this study. 
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The study investigator acquired a structural brain image of the subject 
using a 3T MRI scanner (Intera, Philips Medical System, The Netherlands) with 
fiducial markers on the scalp at vertex and 5 cm anterior, posterior, left and right 
of vertex. The investigator imported the images into a frameless stereotaxy 
system called Brainsight™ (Rogue Research Inc., Montreal, Quebec, Canada). 
Then, he co-registered the images to Brainsight™ using left and right tragus, 
nasion, tip of nose, and five fiducial markers. Finally, the investigator identified 
the center of the TMS coil with the system's calibration block. 
The subject, with the help of the investigator, placed a Lycra® swim cap 
over the scalp. The TMS administrators positioned themselves in such a way 
that they could not view the Brainsight™ program running in real time or the TMS 
machine output. With help from the investigator, the subject sat in a chair placing 
his chin in a chin rest and his head against a support. The Dantec Cantata ™ 
(Copenhagen, Denmark) recorded MEP's of the relaxed abductor pollicis brevis 
(APB). Study personnel placed the Ag-AgCI surface EMG electrode over the 
belly of the target muscle and the reference on the palmar side of the proximal 
phalange. (See figure 1) 
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not find the EMG motor hot spot within 1 cm of the OM motor hot spot for both 
MT sessions. Even within method, the distance between the first and second 
EMG MT sites and first and second OM MT sites was greater than 1 cm for eight 
and six TMS administrators. None of the TMS administrators kept all four MT 
sites to within 1 cm of one another. The wide distribution of optimal MT sites 
identified by the TMS administrators is alarming since most TMS depression 
studies rely on this location to anchor the TMS treatment. 
Figure 2. All motor thresholds and treatment sites. 
Key: 
Black = MT by experienced administrator. 
Blue = MT by nurse. 
Yellow = Treatment site by experienced administrator. 
Red = Treatment site by nurse. 
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demonstrated over one hundred years ago (D'Arsonval, 1896). In the early 
1980's, Barker and colleagues modernized the TMS device and stimulated the 
motor cortex of the human brain with time-varying magnetic fields, causing visible 
twitching and recordable muscle action potentials in the contralateral fingers 
(Barker et aI., 1985). TMS was a vast improvement over direct brain electrical 
stimulation for investigating brain function and excitability, since TMS is mostly 
painless, easily administered, and can be focused on a specific area of the brain 
without exposing brain tissue (Barker, Freeston, Jalinous, & Jarratt, 1987; Merton 
& Morton, 1980). 
In the early 1990's, researchers studied the effects that TMS applied over 
the dorsolateral prefrontal cortex (DLPFC) had on the symptoms of depression 
(George et aI., 1995). Since then, scores of small TMS studies have tested 
various TMS parameters on depressed subjects. From these small TMS studies, 
several meta-analyses of TMS literature concluded that TMS had antidepressant 
properties (Burt, LisanbYJ & Sackeim, 2002; F. A. Kozel & George, 2002; Martin 
et aI., 2002; McNamara, Ray, Arthurs, & Boniface, 2001). In 2007, the largest 
TMS study for unipolar depression (n = 301) showed that four weeks of TMS had 
greater antidepressant effects than sham TMS in a less ill subgroup of their study 
population (O'Reardon et aI., 2007b). Depression is by far the most studied 
disorder and the only treatment indication approved by the FDA. Meanwhile, 
TMS studies in schizophrenia, post-traumatic stress disorder, obsessive-
compulsive disorder, personality disorders, panic disorder, tinnitus, Parkinson's 
disease, and Tourette's syndrome are ongoing (see www.clinicaltrials.gov). In 
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addition, the analgesic properties of TMS are under investigation (Borckardt et 
aI., 2006). 
TMS DEVICE: 
The capacitors and coil are the two main parts of a TMS machine. 
Energy is stored in the capacitors, and then discharged though the coil as 
needed. The capacitors dimensions vary between manufacturers, but most are 
the size of a medium suitcase and plug into a standard 110 volt power outlet. 
The TMS coil is a figure-eight design that contains metal windings inside a hard 
plastic insulating cover that prevents electric shock from current passing through 
the coil. Other coil designs include a singular circular configuration that produces 
a less focused magnetic field than the figure-eight coil; a deep cone design that 
reaches deeper brain areas than the tradition figure-eight coil; and the iron-core 
coils that are compact and heavy. The magnetic field produced by the TMS 
device is about the same as an MRI machine (1-3 tesla); however, the magnetic 
field dissipates rapidly from the TMS coil's face and the magnetic field is 
exceedingly brief (only milliseconds). 
Depending on the efficiency of the coil, and how intense and frequent the 
TMS coil is discharging over time, the electric current passing through the coil 
can generate enough heat in the coil to burn the scalp, if internal coil temperature 
monitoring did not shut down the machine at a pre-set thermal limit. Most TMS 
coils have an apparatus that cools the TMS coil to allow higher doses. For 
example, loud and cumbersome blower systems use ambient or cold air to help 
dissipate heat from the TMS coil. Fluid cooled coils are efficient at removing heat 
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from the coil, but are more challenging to manufacture and not in widespread 
use. Some TMS coils, especially the solid core coils, relay on radiant heat loss, 
but this method may not keep coils cool at higher therapeutic intensities. 
The TMS treatment procedure consists of locating the motor hot spot, 
estimating the motor threshold intensity, locating the treatment site, and 
delivering stimulation at the optimal rate and duration to maximize outcomes. 
The motor threshold (MT) refers to the intensity required to depolarize motor 
neurons, which causes movement in contralateral muscles and provides an 
estimate of cortical excitability. The motor hot spot is the optimal scalp location 
for eliciting muscle movement. The intensity of a TMS treatment is typically 
1200/0 of the motor threshold estimate and the TMS coil is positioned 5 cm 
anterior of the optimal MT site. The MT determination is an essential element of 
TMS treatments and requires skill and practice. 
Several companies manufacture TMS devices for mapping brain function 
with single pulse stimulation, but the NeuroStar TMS Therapy System 
(Neuronetics, Inc., Philadelphia, Pennsylvania) is the only TMS device cleared by 
the FDA for treating unipolar depression. The use of any other TMS device for 
the treatment of depression is off label. 
LOCALIZATION OF THE MOTOR THREHOLD: 
Stimulating over the brain's motor cortex causes movement in 
contralateral muscles. The muscles of the hand are the most convenient 
muscles to find and require the least amount of machine power to activate. The 
abductor pollicis brevis (APB) or thumb muscle is the preferred target for 
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estimating cortical excitability and is roughly 5 cm lateral of vertex (Cz) toward 
the tragus of the ear on the interaural line. Clinicians can use the center of 
gravity (COG) technique or an abbreviated COG technique to locate the optimal 
site on the scalp to stimulate the APB MT. The COG involves stimulating at 1 cm 
interval in a grid pattern over the motor cortex and recording motor evoked 
potentials (MEP) with surface electromyography (EMG) electrodes. The optimal 
MT location or hot spot is the scalp site with the weighted average of the highest 
MEP with the lowest intensity. The COG technique is time consuming and 
requires considerable EMG knowledge. Most TMS clinicians treating depression 
have shortened the COG process by simply moving the coil over the motor 
cortex until finding strong MEPs or thumb movements. 
To find the MT hot spot using the abbreviated COG locating technique, the 
patient sits in a comfortable chair with head support. The clinician attaches the 
EMG electrodes to the patient's right hand. The patient's hand, fingers, and 
thumb should be relaxed and not opposing gravity during the MT procedure. To 
ensure the patients hand is at rest, an EMG can monitor the patient's hand and 
provide audio and visual feedback when muscle activity occurs. 
The MT starting position is 5 cm lateral of the vertex along the interaural 
line on the left side of the head. The starting position (5 cm lateral of CZ) is the 
center point of a 5 cm grid over the motor cortex. The patient may wear a swim 
cap with a grid drawn on the cap to help track the coil's position. The clinician 
places the center of the TMS coil over the starting point and gives 1 pulse every 
3-5 seconds at an intensity of 300/0 machine output. Then, the clinician moves 
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the coil in 1 cm increments over the grid giving one pulse at each point, 
monitoring for positive responses from each magnetic pulse. A positive response 
is a MEP of 50uV or observed movement of the thumb when an EMG is 
unavailable. If no positive responses result, the intensity increases by 100/0 of 
machine output and the procedure repeated. When a positive response is noted, 
the intensity decreases by 5% and each point on the grid rechecked. The 
clinician makes minor intensity adjustments (2-3%) until positive responses are 
reliable. When the clinician finds the optimal MT location with confidence, they 
record the site by outlining the coil on the scalp with an indelible pen or by using 
a measuring apparatus provided by some TMS manufacturers. This site is the 
MT hot spot. 
The patient's hand is at rest during the MT; however, an active thumb or 
the "hitchhiker thumb" can help quickly locate the MT hot spot since it requires 
less machine output to activate contracted muscles. The clinician must switch to 
a resting MT hunt once hitchhiker thumb movements help narrow the search. 
Knowing the motor homunculus will also help the clinician find the MT hot spot 
faster. For example, the hot spot for the thumb is just medial of the lips and 
lateral of the little finger (Nakamura et aI., 1998). 
There are several alternative techniques to find the MT hot spot including 
the hand knob, fMRI, and use of anatomical scalp measures. Briefly, the hand 
knob is a unique brain structure identified on an MRI that contains the MT hot 
spot. With a functional MRI, the patient moves his or her thumb while the MRI 
records blood flow. The center of activation identified by the fMRI is the MT hot 
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spot. Both of these methods are expensive due to the cost of an MRI. Further, 
both methods require the use of a frameless stereotactic system to relate brain 
coordinates to a scalp location and TMS coil placement. The third alternative 
technique uses a simple flexible measuring tape to find a standard MT location at 
approximately 5 cm lateral of vertex. Clinical practitioners do not commonly use 
these alternative MT locating techniques. 
MOTOR THRESHOLD ESTIMATE: 
The motor threshold estimate is the lowest intensity that consistently elicits 
positive motor responses. Clinicians may use the EMG MT method and consider 
an MEP amplitude of 50 J,JV as a positive response or utilize the observation of 
movement (OM) MT method and count movement of the thumb as a positive 
response in resting muscles. The use of the OM method is controversial and the 
EMG method is more conservative. 
Five positive responses out of 10 stimuli has been the standard criteria for 
consistent positive responses; however, new computer algorithms have replaced 
the 5 out 10 rule. Maximum-likelihood algorithms dictate the next intenSity of 
machine output based on negative and positive muscle responses and predicts 
the MT with just a few pulses. TMS manufactures may provide an algorithm 
program with their equipment or clinicians may use a free algorithm program 
found at www.clinicalresearcher.org. 
To perform the MT estimate, the clinician places the TMS coil over the MT 
hot spot and starts stimulation at 300/0 machine output. The clinician may choose 
to start at 10% machine output lower than the rough MT estimate known from the 
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MT localization procedure. This will speed up the MT process. A positive or 
negative muscle response to the magnetic pulse is recorded in the computer 
algorithm. The program dictates the intensity of the next pulse. The clinician 
should wait 3-5 seconds before given the next pulse so that the brain can 
recover, thus preventing false positive or negative responses. 
There are several alternative methods of estimating the MT. Rossini et al. 
suggests slowly increasing intensity until MEP amplitudes of 100 IJV in 500/0 of 10 
consecutive stimuli are recorded, while Rothwell et al. suggest starting with supra 
threshold and decreasing intensity until the MT is found (Rossini et al.! 1994; 
Rothwell et aI., 1999). Mills and Nithis average the upper threshold and lower 
threshold to yield the overall MT for an individual. They consider a positive 
response as having an MEPs of 20 IJV and the upper threshold as 10 
consecutive positive responses and the lower threshold as 10 consecutive 
negative responses (Mills & Nithi, 1997). These methods require an EM~, 
though many clinicians substitute thumb movements for positive EMG response 
when applying these formulas. A detailed review of MT methods is outside the 
scope of this paper, but available by Anderson and George, 2009. 
LOCALIZATION OF TREATMENT SITE: 
The TMS treatment site over the DLPFC is commonly localized 5 cm 
anterior in a parasagittal plane from the scalp location of the MT hot spot. 
However, this 5 cm rule may be short of the DLPFC in some patients and 
clinician may need to increase the distance to 6 cm (Herbsman et aI., 2009; 
Herwig et aI., 2001; Herwig et aI., 2003). The simplicity of using a flexible ruler to 
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measure 5 cm from the motor hot spot has attracted the majority of TMS 
clinicians. None the less, another low cost method of localizing the DLPFC 
known as the F3 method is gaining popularity. F3 is a scalp location over the 
DLPFC named by the International 10-20 system for electroencephalography 
(EEG) electrode placement (Jasper, 1958). The F3 method uses the nasion-
ionin line, interaural line, and several other head measurements to find the MT 
treatment site. MRI guided is a third method of localizing the treatment site, but it 
may be too expensive for clinical use. 
TREATMENT PARAMETERS: 
TMS treatment parameters consist of the coils location, Hz or pulses per 
second, on time, off time, intensity, and total number of pulses per session. The 
right DLPFC is the preferred location for 1 Hz (one pulse per second) TMS for 
depression. This right sided slow stimulation may help the symptoms of 
depression and anxiety, but it has not received as much research as has left 
sided stimulation. The FDA labeling calls for fast (10Hz) TMS applied to the left 
DLPFC. Fast TMS is stimulation given at greater than 1 Hz. It is uncommon to 
give fast stimulation on the right side or slow stimulation on the left. 
The on time for TMS, known as a train, is 4-5 seconds in duration. There 
must be a short rest period known as off time for 10-30 seconds between trains. 
The off time allows the brain to rest and recover from the stimulation. The 
intensity is the power output of the TMS device and is expressed as a percent of 
the motor threshold. For example, if the prescribed intensity is 1200/0 of MT and 
the patient's MT is 62% of total machine output, the treatment intensity is 78% of 
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total machine output (1.20 X 65 = 78). Therefore, the percent of machine output 
is unique to every TMS device. 
The total number of pulses per session is usually around 3000 in one 
session. Some clinicians administer two sessions in one day with a short break 
in between to maximize the treatment day, although one session per day is the 
norm. Each TMS session takes about 30-40 minutes to complete. An acute 
TMS treatment for depression is one session per day for 5 days a week. A 
common TMS treatment regiment for depression is left DLPFC at 10Hz, 4 
seconds on, 26 seconds off, 3000 total pulse for 4 weeks. It is likely that 
clinicians will increase the total number of pulses and shorten the off time as 
more safety information becomes available. Treatment parameters should stay 
within current safety tables (Wassermann, 1998). 
SAFETY: 
TMS is a safe and efficient treatment for depression, but can produce 
unwanted side effects. Although rare, seizure is the most notable side effect 
related to TMS (Lao, McFarquhar, & Mitchell, 2008). To reduce the risk of 
seizure, patients with known seizure disorders or disorders that increase 
intracranial pressure are not treated. Clinicians cautiously treat patient taking 
medications that lower the seizure threshold, such as stimulants, tricyclic 
antidepressants, and bupropion. TMS guidelines by Wassermann et al. (1998) 
give known parameters that reduce the risk of seizure. 
Patients with cochlear implant, aneurysm clips, brain electrodes, or 
ferromagnetic material in their head or neck may not have TMS. Patients with 
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most types of dental products can have TMS. Stroke and head trauma are 
contraindications to TMS. Clinicians take special precautions on patients with 
cardiac pacemakers or implanted medication pumps. 
The most common side effect for TMS is headache and discomfort at the 
site of stimulation. Headaches usually resolve within an hour; some patients pre-
treat with acetaminophen just before the TMS session. Site pain during 
stimulation occurs under the TMS coil, but it seems to dissipate for most patients 
after a few TMS sessions (Anderson et aI., 2009). For patient comfort, clinicians 
may adjust the intensity of the first session and then increase to the target 
intensity over the next few days. It is normal to have twitching of the eyebrow 
during the pulse train, but mouth and jaw twitching during stimulation may 
indicate poor coil placement. 
The FDA approved TMS machine is a class II device for prescription use. 
Each state regulates prescriptive authority, which includes nurse practitioners. 
Physicians or clinicians with prescriptive authority dictate the dose of TMS, but 
other clinicians usually administer the TMS treatment. The person administering 
TMS is medically trained and able to manage a seizure. Previous seizures 
related to TMS were short in duration and self limiting; however, TMS clinics 
must be prepared to deal with this medical emergency and a clear written seizure 




The use of TMS as treatment for depression is growing exponentially. 
Nurses have an opportunity to shape the future of this new technology, as they 
are well suited to administer TMS and manage possible adverse events, such as 
seizure. Currently, there are no standard TMS training protocols for nurses. As 
the frontline providers of TMS, nurses need to establish TMS training certification 
courses and other TMS related educational opportunities for nurses. Learning 
how to administer TMS safely and effectively requires much more than reading a 
manual; it requires hands on instruction and practice. Procedures that test the 
TMS administrator's ability to determine the MT and treatment sites may increase 
treatment delivery uniformity across TMS clinics, thus yielding more effective 
treatments for patients. 
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CONCLUSION 
This dissertation document consists of three manuscripts; (1) a review of 
literature, (2) methods and research findings, and (3) an introduction to TMS in 
clinical settings. The information found in this document will help nurses as 
premier providers of TMS establish TMS administration and training protocols. 
The literature review shows that despite the relatively small evidence to support 
the assertion that the OM method is similar to the EMG-assisted method for 
determining motor threshold in clinical settings, many clinicians are using the 
faster, less complicated OM method. The lack of a consensus on how to perform 
the motor threshold procedure likely effects treatment outcomes. 
This study showed that the mean differences between OM and EMG 
methods were small, but it revealed the inconsistent nature of the MT procedure. 
Both methods failed to identify the optimal treatment location in most cases. 
The EMG or OM method along with the 5 cm rule may position the coil posterior 
and medial to the intended location. Study results indicate the need for 
developing other methods for determining TMS intensity and treatment location. 
In this study, nurses with minimal TMS training were able to perform the 
MT procedure with similar accuracy as experienced TMS administrators. This 
study suggests that nurses can learn the MT procedure quickly and can be 
effective TMS administrators. There is a need, therefore, for nurse directed TMS 
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training and TMS administration certifications. The methods for recording coil 
placement used in this study are excellent techniques for testing the accuracy of 
TMS trainees. Holding all TMS administrators to high uniform standards ensures 
consistency across TMS clinics and positive outcomes for depressed patients. 
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APPENDIX - ALL COORDINATES FOR ALL SUBJECTS 
x y z 
Lear 153.576935 125.8125 111.100006 
Rear 4.125 132.6875 114.537506 
TipNose 76.3125 13.0625 100.787498 
bridge Nose 78.375 36.4375 145.475006 
Cz 84.166672 156 246.933334 
AntCz 84.891304 108.333336 243.020294 
PostCz 86.5 195.666672 233.600021 
LeftCz 129.833344 150.333344 228.93335 
RightCZ 37.166668 155 233.600021 
a011aemt 137.446808 140.555557 222.127655 
a011aetx 123.404259 80.361115 209.787231 
a011 bvmt 118.723412 128.027786 235.319153 
a011 bvtx 105.106384 69.666672 216.595734 
a012avmt 126.808517 162.555573 230.212769 
a012avtx 119.574471 80.361115 214.468079 
a012bemt 136.595749 151.555573 223.404251 
a012betx 116.595749 79.75 216.595734 
a021aemt 124.347824 131.772736 232.753632 
a021aetx 110.434784 83.886787 225.217392 
a021 bvmt 128.695648 146.641663 228.985504 
a021 bvtx 113.04348 97.157677 229.565216 
a022avmt 130.434784 153.541275 227.536224 
a022avtx 119.420288 101.435791 227.82608 
a022bemt 120.86956 157.220428 235.36232 
a022betx 111.5942 105.378632 234.782608 
a031aemt 136.773514 128.039658 220.147324 
a031aetx 125.714279 89.523804 213.015869 
a031bvmt 132.421005 132.057495 227.020386 
a032avtx 109.223557 95.216995 230.20726 
a032bemt 132.787048 128.973419 224.702881 
a031 bvtx 119.895241 88.912842 218.335602 
a032avmt 118.193565 137.673782 236.674744 
a032betx 122.441467 85.69445 214.611786 
a041avmt 124.077217 150.499939 232.146378 
a041avtx 123.675552 103.343468 224.371674 
a041bemt 126.597435 153.624008 230.735962 
a041 betx 127.618065 114.769661 225.476456 
a042aemt 119.199074 154.812775 235.429749 
a04aetx 127.695915 118.289612 226.292664 
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a042bemt 122.111893 161.567886 233.010574 
a042betx 126.869881 117.513626 226.49733 
a051avmt 108.748055 137.892883 241.355408 
a051 avtx 101.403557 107.67569 239.296051 
a051 bemt 106.456741 140.660431 242.85907 
a051 betx 110.18222 105.21286 234.573273 
a052aemt 108.20681 130.880447 240.531693 
a052aetx 98.977432 98.709496 237.245773 
a052bvmt 115.555328 129.505203 236.995758 
a052bvtx 107.620575 104.961853 235.225357 
a061avmt 114.457787 144.168106 239.552292 
a061 avtx 111.697586 96.111969 229.69014 
a061bemt 117.805244 173.372269 233.280609 
a061 betx 116.087593 118.078789 235.344238 
a06saemt 108.05101 173.908768 237.34964 
a062aetx 105.649498 123.517525 240.854141 
a062bvmt 113.391052 158.917847 238.930923 
a062bvtx 107.380135 112.586823 237.623093 
a07avmt 121.682915 142.6259 235.010132 
a07avtx 100.735146 96.46637 235.499466 
a071bemt 121.502235 141.583908 234.354538 
a071 betx 112.234978 91.112785 226.817017 
a072aemt 104.025711 155.128372 242.274078 
a072aetx 109.266899 108.105812 235.75119 
a072bvmt 110.477127 148.985855 240.627655 
a072bvtx 102.675125 99.643814 236.410706 
a081aemt 120.070297 154.05864 234.919281 
a081aetx 99.178596 91.88765 234.185074 
a081 bvmt 112.361137 153.813217 239.348877 
a081 bvtx 98.522621 99.93557 237.886337 
a082avmt 107.803085 153.684952 240.988022 
a082avtx 87.954872 98.508911 239.603149 
a082bemt 112.804199 144.804855 239.174728 
a082betx 94.941711 96.493774 237.991531 
a091aemt 113.944473 161.958374 237.647156 
a091aetx 110.192474 114.962219 236.897568 
a091 bvmt 112.539017 175.345901 234.788315 
a091 bvtx 114.295662 125.598816 237.249435 
a092avmt 117.67025 170.073471 233.620758 
a092avtx 121.978355 117.106804 231.375244 
a092bemt 122.123329 173.714371 230.220139 
a092betx 119.910522 114.797112 231.622513 
a1 01 avmt 136.902328 154.096481 221.638885 
a1 01 avtx 119.136627 109.630676 229.391617 
a101bemt 114.213181 138.728485 238.496658 
a1 01 betx 102.852135 94.232338 233.697647 
a102aemt 120.832535 144.34581 234.387665 
a102aetx 105.447067 96.713196 233.596054 
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a102bvmt 115.16375 139.164017 237.673645 
a102bvtx 108.488159 101.04483 233.143387 
a111aemt 129.098312 166.232651 227.850754 
a111 aetx 129.2509 117.296738 225.072708 
a111 bvmt 128.960846 132.639893 228.212708 
a111 bvtx 133.671524 102.515373 213.224213 
a112avmt 122.481224 149.709137 234.096786 
a112avtx 115.957695 105.100403 230.876144 
a112bemt 122.729965 129.640732 232.789413 
a112betx 118.943962 90.898346 221.654785 
a121aemt 149.37056 143.480438 205.025253 
a121aetx 140.31044 114.582191 208.522263 
a121 bvmt 135.487091 155.400986 223.533554 
a121 bvtx 133.839767 111.02137 216.021927 
a122avmt 134.368729 160.621475 222.911575 
a122avtx 135.143097 110.980347 214.604919 
a122bemt 152.025192 144.143982 200.755783 
a122betx 136.474289 115.496048 214.120529 
a131avmt 132.660599 157.715942 224.507507 
a131 avtx 121.504715 115.46936 231.413513 
a131 bemt 131.8423 142.751755 227.567749 
a131 betx 121.347176 96.880959 222.01622 
a132aemy 129.42186 141.118729 228.066864 
a132aetx 124.457184 109.427902 226.450348 
a132bvmt 132.265411 140.048492 226.143051 
a132bvtx 117.392014 104.4832 229.312225 
a141avmt 116.459541 162.520538 235.523727 
a141avtx 111.20533 118.288635 237.181046 
a141 bemt 122.87059 170.923813 230.742172 
a141 betx 116.171265 125.76075 236.287369 
a142aemt 120.259796 163.892227 233.973831 
a142aetx 114.005165 121.4534 236.629593 
a142bvmt 119.600876 163.983643 234.306564 
a142bvtx 114.831078 117.890968 236.200256 
a151aemt 124.820961 155.54924 232.592499 
a151aetx 113.711525 112.778786 234.843079 
a151 bvmt 116.835358 151.944794 237.558578 
a151 bvtx 105.399864 108.824028 238.066711 
a152avmt 129.176086 160.88942 228.17627 
a152avtx 108.9319 105.732819 235.958542 
a152aemt 123.607719 151.656311 233.960999 
a152aetx 111.990051 107.507027 234.835953 
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